TXG:NSD-10X Genomics Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 14.91

Change

-0.77 (-4.91)%

Market Cap

N/A

Volume

2.10M

Analyst Target

USD 120.25
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

-0.74 (-0.87%)

USD 39.84B
TEM Tempus AI, Inc. Class A Common..

+0.04 (+0.06%)

USD 7.92B
HQY HealthEquity Inc

-5.40 (-5.39%)

USD 7.54B
RCM R1 RCM Inc

+0.01 (+0.07%)

USD 6.02B
WAY Waystar Holding Corp. Common S..

-0.15 (-0.47%)

USD 4.47B
BTSG BrightSpring Health Services, ..

+0.12 (+0.61%)

USD 2.71B
GDRX Goodrx Holdings Inc

-0.04 (-0.85%)

USD 2.43B
WGS GeneDx Holdings Corp.

+1.56 (+2.03%)

USD 2.29B
PRVA Privia Health Group Inc

-0.74 (-3.28%)

USD 2.27B
OMCL Omnicell Inc

-1.08 (-2.21%)

USD 2.24B

ETFs Containing TXG

SGDM Sprott Gold Miners ETF 4.73 % 0.57 %

-0.43 (-0.43%)

USD 0.27B
ZGD:CA BMO Equal Weight Global G.. 2.86 % 0.61 %

-0.51 (-0.43%)

CAD 0.11B
CGV Two Roads Shared Trust 1.48 % 0.00 %

-0.06 (-0.43%)

USD 0.11B
PZC:CA 0.00 % 0.67 %

N/A

N/A
GOAU U.S. Global GO GOLD and P.. 0.00 % 0.60 %

-0.22 (-0.43%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -73.36% 13% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -73.36% 13% F 9% A-
Trailing 12 Months  
Capital Gain -63.10% 25% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -63.10% 25% F 12% F
Trailing 5 Years  
Capital Gain -78.03% 33% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -78.03% 33% F 16% F
Average Annual (5 Year Horizon)  
Capital Gain 1.76% 63% D 44% F
Dividend Return 1.76% 63% D 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 72.89% 24% F 28% F
Risk Adjusted Return 2.42% 63% D 36% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.